search
Back to results

Micronutrient Supplement Effects on Cognitive Outcomes in Post-Acute TBI

Primary Purpose

Traumatic Brain Injury

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Swisse Womens 50+ Ultivite Multivitamin
Holland and Barrett Triple Strength Omega-3 Fish Oil
Sponsored by
Sheffield Hallam University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Traumatic Brain Injury focused on measuring TBI

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • First and only traumatic brain injury.
  • Complex mild to moderate injury.
  • 3-24 months post-injury

Exclusion Criteria:

  • Unable to give informed consent.
  • Already taking micronutrient/fatty acid supplements.
  • Hemianopia
  • Hemiplegia.
  • Pregnant or breastfeeding.
  • Diagnosed with clinically low blood pressure, diabetes, or disease of neurodegeneration.

Sites / Locations

  • Sheffield Hallam University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

No Intervention

Arm Label

Multivitamin

Omega-3 Fatty Acids

Control

Arm Description

Swisse Womens 50+ Ultivite Multivitamin. Once daily.

Holland and Barrett Triple Strength Omega-3 Fish Oils. Once Daily

Treatment as usual (cognitive rehabilitation, occupational therapy, physiotherapy; as required)

Outcomes

Primary Outcome Measures

Performance on cognitive test measures (a battery of standardized tests; memory, executive function, social cognition, general intelligence, learning and processing speed)
Analysis of change in cognitive test battery results between each time point (T2 minus T1. T3 minus T2. T3 minus T1)

Secondary Outcome Measures

Average dietary intake of micronutrients and fatty acids
Analysis of dietary intake via Nutritics software (https://www.nutritics.com/p/references), average intake value for each micronutrient supplied by software output. This will be compared to recommended daily amounts to evaluate levels of sufficiency/insufficiency in each participant.

Full Information

First Posted
December 22, 2016
Last Updated
October 20, 2020
Sponsor
Sheffield Hallam University
Collaborators
Sheffield Teaching Hospitals NHS Foundation Trust, Rotherham Doncaster and South Humber NHS Foundation Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT03032302
Brief Title
Micronutrient Supplement Effects on Cognitive Outcomes in Post-Acute TBI
Official Title
Micronutrient Intervention Effects on Cognitive Outcomes in Post-Acute Traumatic Brain Injury
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
October 1, 2017 (Actual)
Primary Completion Date
April 18, 2020 (Actual)
Study Completion Date
April 18, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Sheffield Hallam University
Collaborators
Sheffield Teaching Hospitals NHS Foundation Trust, Rotherham Doncaster and South Humber NHS Foundation Trust

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Traumatic brain injury (TBI) refers to neuronal damage occurring as the result of an external force being applied to brain tissue. In the United Kingdom annual figures (2013-2014) show 449,000 hospital admittances with a diagnosis of head injury with males up to five times more likely to sustain a head injury than females. Traumatic brain injury (TBI) causes life-long disability, with no significant reduction in life expectancy, affecting a diverse range of cognitive and social functions including memory, task planning and execution, impulse control, social interactions, personality changes and depression. Following traumatic brain injury acquired deficits can lead to problems with resumption of aspects of daily life, particularly in terms of returning to work and interpersonal relationships. The initial injury triggers a secondary cascade of metabolic, neurochemical and cellular changes within the brain, primarily aimed at limiting damage and stimulating repair. Paradoxically prolonged secondary cascade mechanisms, including haemorrhage, oedema, neuroinflammation and axonal injury, results in exacerbation of deficits observed. The heterogeneous on-going nature of the secondary cascade presents clinicians with opportunities to intervene in an attempt to limit neuronal damage. A large body of nutritional research has been focused on addressing the hypermetabolic and catabolic states created by secondary cascade processes in the acute stage. Addressing these demands has played a significant role in reducing mortality and infection rates following head injury, however there has not been the same depth of research investigating the post-acute period (once individuals are discharged from hospital).
Detailed Description
Micronutrients (including vitamins, minerals and certain polyunsaturated fatty acids) are required by the brain for normal functioning and, with few exceptions, can only be obtained through dietary sources. Research into degenerative diseases of aging have linked mitochondrial aging and DNA damage caused by micronutrient deficiency to greater incidence of cognitive decline and stroke, among other diseases, in the general population, particularly in those consuming food rich in fats and carbohydrates but poor in micronutrient content. Other research focusing on cognition, behaviour and mood state has associated micronutrient deficiencies with a wide range of neurological conditions including Alzheimer's Disease, Parkinson's Disease, multiple sclerosis, autism spectrum disorders, depression, fatigue and schizophrenia. There have however been very few studies using micronutrient interventions in post-acute human TBI. In a study with thirty retired American Football players an intervention including supplementation with a broad-spectrum multivitamin, omega-3 fish oils and a number of other substances resulted in significant percentile score improvements in almost half of the participants (n=100) across a broad range of cognitive measures. Findings demonstrated that micronutrient intervention can result in significant measurable improvements in those with TBI many years following the initial insult. A normative study will be conducted with three groups assigned to Vit D, Vit C and multivitamin arms (N = 60) tested at baseline on cognitive function and post-intervention. The TBI study will recruit three groups of individuals with post-acute traumatic brain injuries and measure whether there is improved cognitive outcomes (measured by test-retest on a cognitive battery) associated with the supplements shown to be most effective in the pilot study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Traumatic Brain Injury
Keywords
TBI

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Multivitamin
Arm Type
Experimental
Arm Description
Swisse Womens 50+ Ultivite Multivitamin. Once daily.
Arm Title
Omega-3 Fatty Acids
Arm Type
Experimental
Arm Description
Holland and Barrett Triple Strength Omega-3 Fish Oils. Once Daily
Arm Title
Control
Arm Type
No Intervention
Arm Description
Treatment as usual (cognitive rehabilitation, occupational therapy, physiotherapy; as required)
Intervention Type
Dietary Supplement
Intervention Name(s)
Swisse Womens 50+ Ultivite Multivitamin
Intervention Description
Single tablet taken once daily
Intervention Type
Dietary Supplement
Intervention Name(s)
Holland and Barrett Triple Strength Omega-3 Fish Oil
Intervention Description
Single capsule taken once daily
Primary Outcome Measure Information:
Title
Performance on cognitive test measures (a battery of standardized tests; memory, executive function, social cognition, general intelligence, learning and processing speed)
Description
Analysis of change in cognitive test battery results between each time point (T2 minus T1. T3 minus T2. T3 minus T1)
Time Frame
Three time points: baseline (T1), 8 weeks (T2) and 22 weeks (T3)
Secondary Outcome Measure Information:
Title
Average dietary intake of micronutrients and fatty acids
Description
Analysis of dietary intake via Nutritics software (https://www.nutritics.com/p/references), average intake value for each micronutrient supplied by software output. This will be compared to recommended daily amounts to evaluate levels of sufficiency/insufficiency in each participant.
Time Frame
Data collected at four time points (3 day diaries) during participant's involvement in the study via participants filling in paper food diary

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: First and only traumatic brain injury. Complex mild to moderate injury. 3-24 months post-injury Exclusion Criteria: Unable to give informed consent. Already taking micronutrient/fatty acid supplements. Hemianopia Hemiplegia. Pregnant or breastfeeding. Diagnosed with clinically low blood pressure, diabetes, or disease of neurodegeneration.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lynne A Barker, PhD
Organizational Affiliation
Sheffield Hallam University
Official's Role
Study Director
Facility Information:
Facility Name
Sheffield Hallam University
City
Sheffield
State/Province
South Yorkshire
ZIP/Postal Code
S10 2BQ
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
16754282
Citation
Lippert-Gruner M, Kuchta J, Hellmich M, Klug N. Neurobehavioural deficits after severe traumatic brain injury (TBI). Brain Inj. 2006 Jun;20(6):569-74. doi: 10.1080/02699050600664467.
Results Reference
background
PubMed Identifier
20483970
Citation
Bombardier CH, Fann JR, Temkin NR, Esselman PC, Barber J, Dikmen SS. Rates of major depressive disorder and clinical outcomes following traumatic brain injury. JAMA. 2010 May 19;303(19):1938-45. doi: 10.1001/jama.2010.599.
Results Reference
background
PubMed Identifier
8083910
Citation
Borzotta AP, Pennings J, Papasadero B, Paxton J, Mardesic S, Borzotta R, Parrott A, Bledsoe F. Enteral versus parenteral nutrition after severe closed head injury. J Trauma. 1994 Sep;37(3):459-68. doi: 10.1097/00005373-199409000-00022.
Results Reference
background
PubMed Identifier
19033220
Citation
Cook AM, Peppard A, Magnuson B. Nutrition considerations in traumatic brain injury. Nutr Clin Pract. 2008 Dec-2009 Jan;23(6):608-20. doi: 10.1177/0884533608326060.
Results Reference
background
PubMed Identifier
20420847
Citation
Ames BN. Optimal micronutrients delay mitochondrial decay and age-associated diseases. Mech Ageing Dev. 2010 Jul-Aug;131(7-8):473-9. doi: 10.1016/j.mad.2010.04.005. Epub 2010 Apr 24.
Results Reference
background
PubMed Identifier
23008220
Citation
Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, Llewellyn DJ, Raina P. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology. 2012 Sep 25;79(13):1397-405. doi: 10.1212/WNL.0b013e31826c197f.
Results Reference
background
PubMed Identifier
24800044
Citation
Bitarafan S, Harirchian MH, Nafissi S, Sahraian MA, Togha M, Siassi F, Saedisomeolia A, Alipour E, Mohammadpour N, Chamary M, Honarvar NM, Saboor-Yaraghi AA. Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients. Iran J Neurol. 2014;13(1):28-32.
Results Reference
background
PubMed Identifier
21102318
Citation
Nimitphong H, Holick MF. Vitamin D, neurocognitive functioning and immunocompetence. Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):7-14. doi: 10.1097/MCO.0b013e3283414c38.
Results Reference
background
PubMed Identifier
18503256
Citation
Oudshoorn C, Mattace-Raso FU, van der Velde N, Colin EM, van der Cammen TJ. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2008;25(6):539-43. doi: 10.1159/000134382. Epub 2008 May 26.
Results Reference
background
PubMed Identifier
21615001
Citation
Amen DG, Wu JC, Taylor D, Willeumier K. Reversing brain damage in former NFL players: implications for traumatic brain injury and substance abuse rehabilitation. J Psychoactive Drugs. 2011 Jan-Mar;43(1):1-5. doi: 10.1080/02791072.2011.566489.
Results Reference
background
Links:
URL
https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/hospital-episode-statistics
Description
Hospital Episode Statistics 2017-18
URL
https://www.nutritics.com/p/references
Description
Nutritics

Learn more about this trial

Micronutrient Supplement Effects on Cognitive Outcomes in Post-Acute TBI

We'll reach out to this number within 24 hrs